Aesica Pharmaceuticals, the global pharmaceutical contract development and manufacturing organisation (CDMO), has secured the 2016 NEPIC Young Achiever of the Year Accolade – making this the sixth time that the company has successfully secured this award in the space of a few years.
The NEPIC, the leading cluster organisation working with the chemical-using industries, including pharmaceuticals, located in the North East of England hub, bestows the award to young professionals in recognition of their achievement of career success through merit, knowledge, skills development and high endeavour.
This year’s winner is Lynsey Watson of Aesica Pharmaceuticals. Lynsey secured a Masters Degree in Medicinal Chemistry from Newcastle University. Post graduation, Lynsey commenced her career at NewChem Technologies as a research assistant, conducting custom- research and development of small molecules and early phase API’s – before returning to Newcastle University to undertake and successfully complete a PhD in Organic Chemistry in 2012.
She began work as a Level 2 chemist and in 2014 progressed to the position of a level 1 chemist – a role that incorporated greater responsibility, customer interaction and guiding numerous products from proof to concept or technical transfer through scale-up and full scale manufacture. The experience she gained proved invaluable and led to her role as project manager for new product introductions in 2015 – making her the youngest person in the history of Aesica to reach and hold a position at that level.“
Lynsey Watson commented: “I feel greatly honoured to have secured this award. The pharmaceutical manufacturing industry in the North East of England affords tremendous career opportunities for many graduates and aspiring young recruits in this field. Indeed, I especially look forward to continuing to play my part in the success of Aesica – working within the company at its world class facilities that deliver high value services from within the North East’s flourishing pharmaceutical manufacturing hub.”
David Lloyd, HR Director at Aesica Pharmaceuticals commented: “We are delighted that for the sixth time, members of our talented staff have won this accolade from the NEPIC. Indeed, at Aesica, we see our skilled personnel as a critical resource that continues to contribute massively to the on-going growth of the company. We therefore nurture that talent and provide a solid career path that attracts such high calibre graduates and committed young professionals into the company in the first place.”
He continued: “We offer the opportunity to excel and achieve significant success and progression, both for themselves and indeed for the company itself. We provide highly structured, team orientated opportunities for such staff – enabling them to carry out quality, value enhancing work across a number of the wide variety of formulation, development, manufacturing and packaging projects that we initiate from our international facilities, including those located in the North East of the U.K.”
About the NEPIC
NEPIC is an award winning membership cluster organisation working with the chemical-using industries in the North East of England. It covers multiple chemistry-focussed industries including pharmaceuticals, biotechnology, fine & speciality chemicals, petrochemicals, polymers & materials, and renewables.
The organisation aims to build on the North East’s already powerful industrial base to make the region one of the most competitive and successful chemical-processing locations in Europe. It works with cluster members to help them develop into successful and sustainable organisations, in a collaborative business environment that nurtures growth potential.
In 2014, NEPIC was the first UK cluster to receive the GOLD standard ESCA accreditation for cluster excellence and its chief executive, Dr. Stan Higgins is currently European Cluster Manager of the Year. In 2015, the NEPIC achieved £3 billion of gross value added to the region through its supportive activities.
About Consort Medical:
- Consort Medical plc is a leading, global, single source drug and delivery device CDMO through its two operating subsidiaries Bespak and Aesica. Consort Medical is at the leading edge of innovation and is committed to investing in patient, clinician and customer driven innovation to create new treatments, new markets and new opportunities
- Aesica is a leading provider of finished dose and active pharmaceutical ingredient (API) development and manufacturing services to pharmaceutical partners.
- Bespak is a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, and injectables products, and the manufacture of devices for the point of care diagnostics market.